BCBSVP-backed Oncology Analytics taps Dean as CEO
Oncology Analytics, an oncology benefits management and analytics company serving health plans, providers and health plan members in the U.S. and Puerto Rico, has appointed Rick Dean as CEO. The appointment is effective immediately. Dr. Mark Fishman, the company's founder and former CEO, will become executive chairman. Previously, Dean worked at Optum, the healthcare services arm of UnitedHealth Group where he was a founding member of Optum Ventures, a digital health-focused fund. Oncology Analytics is backed by BlueCross BlueShield Venture Partners.
2 November 2017•3 mins read
